Search Results
Found 1 results
510(k) Data Aggregation
(191 days)
The Redsense device is intended to monitor for potential blood loss from the hemodialysis access site in hemodialysis patients undergoing continuous hemodialysis treatment up to 5 hours in the clinical setting. The device includes a blood sensor incorporated into an adhesive sensor patch. The sensor monitors potential blood leakage from the venous needle puncture site via an infrared light and will alarm if blood leakage is detected via absorption onto the device's sensor patch.
Redsense is a system for monitoring the vein or arterial needle during hemodialysis. Redsense consists of an alarm unit and infrared sensor incorporated into an adhesive patch. The patch with the sensor is placed around the vein or arterial needle and detects any blood that drips onto the patch if the needle has been accidentally pulled out or if there is leakage during dialysis. If blood loss is detected, the device will alarm.
Here's a summary of the acceptance criteria and study information for the Redsense device, based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
The provided document does not explicitly state quantitative acceptance criteria for the Redsense device's performance. Instead, it indicates that "Verification testing has been performed to verify that the Redsense device fulfills the Requirement Specifications" and "Results showed the device functioned successfully in the clinical environment."
Based on the device's functional description, the primary performance metric would be its ability to detect blood leakage and alarm. The closest stated performance characteristic is:
| Parameter | Acceptance Criteria (Implied) | Reported Device Performance |
|---|---|---|
| Blood amount for detection | Not explicitly stated as acceptance criteria, but mentioned as device capability | Approximately 2 ml |
| Functionality in clinical environment | Device functions successfully in the clinical environment. | Device functioned successfully in the clinical environment. |
2. Sample Size for the Test Set and Data Provenance
- Sample Size for the Test Set: Not explicitly stated. The document mentions "clinical testing was conducted" but does not specify the number of patients or cases.
- Data Provenance: Prospective (clinical testing).
- Country of Origin: Sweden (Departments of Nephrology/Medicine at Eksjö, Halmstad, Hässleholm, Skövde, and Varberg Hospitals).
3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications
This information is not provided in the document. The study involved clinical testing in hospitals, implying medical professionals were involved in observing and confirming events, but the specific number or qualifications of experts establishing ground truth are not detailed.
4. Adjudication Method for the Test Set
This information is not provided in the document.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
- Was an MRMC study done? No. The document describes a study to verify the Redsense device's functionality, not a comparative effectiveness study involving human readers with and without AI assistance.
- Effect Size of human readers improvement with AI vs without AI assistance: Not applicable, as no MRMC comparative effectiveness study was performed.
6. Standalone (Algorithm Only) Performance Study
Yes, a standalone study (clinical testing) was performed. The provided text describes the Redsense device, which includes a sensor and an alarm unit, as a standalone system designed to detect blood leakage. The clinical testing was conducted to verify that "the Redsense device fulfills the Requirement Specifications" and "functioned successfully in the clinical environment." This implies the device's performance was evaluated independently.
7. Type of Ground Truth Used
The ground truth for the clinical testing would have been clinical observation of actual blood leakage and confirmation by medical staff during hemodialysis treatments. This is inferred from the description of the device's purpose and the clinical study setting.
8. Sample Size for the Training Set
This information is not provided in the document. The Redsense device is described as a sensor-based system, and there is no mention of an "AI" or "algorithm" that would typically require a training set in the context of machine learning. The "Verification testing" and "Clinical testing" refer to the testing of the final, built device.
9. How the Ground Truth for the Training Set Was Established
This information is not provided and is likely not applicable, as the device is not described as utilizing a machine learning algorithm that requires a training set with established ground truth. It appears to be a direct physical sensor detecting infrared light absorption by blood.
Ask a specific question about this device
Page 1 of 1